Alexion sales and marketing update

Alexion said it reached a funding agreement with Germany for Strensiq asfotase alfa to treat pediatric-onset hypophosphatasia (HPP) and Kanuma sebelipase alfa to treat lysosomal acid lipase (LAL) d...